Peter S Pang
Indiana University · Northwestern University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter S Pang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03302910 · Short Stay Unit vs Hospitalization in Acute Heart FailureIndiana University · completed · Acute Heart Failure · principal investigator
- Ph2NCT03259165 · Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot TrialIndiana University · terminated · Heart Failure, Heart Failure Acute, Acute Cardiac Failure · principal investigator
- Ph2NCT03136198 · B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot TrialIndiana University · completed · Heart Failure, Heart Failure Acute, Acute Cardiac Pulmonary Edema · principal investigator
- N/ANCT02592135 · High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)Indiana University · completed · Heart Failure · principal investigator
- N/ANCT01615926 · Assessment of The Clinical Course of Dyspnea in Acute Heart Failure PatientsNorthwestern University · terminated · Acute Heart Failure, Dyspnea · principal investigator
- N/ANCT01614860 · Identification of Patient Phenotypes Associated With Elevated Aldosterone LevelsNorthwestern University · completed · Acute Heart Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Using Short Stay Units (SSU) Instead of Routine Admission to Improve Patient Centered Health Outcomes for Acute Heart Failure (AHF) Patients.R01HS025411 · AHRQ · INDIANA UNIVERSITY INDIANAPOLIS · fiscal years 2017 to 2020 · $358,501 awarded in 2020Same name and institution; not confirmed by an ID
- B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure (BLUSHED-AHF)R34HL136986 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · fiscal years 2017 to 2018 · $358,254 awarded in 2018Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Multidisciplinary Clinical and Translational Science (MCTS) Program (KL2)KL2RR025740 · NCRR · NORTHWESTERN UNIVERSITY · PI Philip Greenland · fiscal years 2008 to 2011Named on NCT01614860
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:05 UTC. The ranking covers the 200 most relevant of 91 PubMed records, and a shared surname and initials can bring in a namesake. All 91 on PubMed
- Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.N Engl J Med · 20141,435 citationsRCR 51.2
- Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.N Engl J Med · 20141,119 citationsRCR 41.4
- 971 citationsRCR 34.8
- 925 citationsRCR 77.9
- 851 citationsRCR 43.7
- 766 citationsRCR 24.5
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.Gastroenterology · 2015647 citationsRCR 25.8
- 452 citationsRCR 15.7
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.N Engl J Med · 2015379 citationsRCR 14.1
- Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.J Am Coll Cardiol · 2013372 citationsRCR 12.3